Let's talk about your

gut flora 

 Happiness in your intestine
Natgene© FLORA  is an innovative analysis based on next-generation DNA sequencing technology (NGS) and able to check the status of general inflammation. In the custom report, in addition to the results, there are nutritional and integration of useful tips to re-establish the correct intestinal balance.
  • check your level of intestinal dysbiosis;
  • evaluate your gut microbiome before and after treatment;
  • compare your gut microbiome with the one of a healthy subject;
  • know your bacterial richness index, the lack of bacterial diversity is correlated with increased risk of chronic inflammation and obesity;
  • identify the bacterial species, pathogenic and beneficial, present in your intestines;
  • calculate your Enterotipo and identify your lifestyle
  • identify and quantify the related intestinal bacteria to inflammation, cardiovascular and musculoskeletal diseases, gastric problems, gluten sensitivity and celiac disease;
  • get simple and targeted nutritional advice and integration processed by a Biologist Nutritionist to improve the welfare of your intestine.

Enterotype section divide People into 3 Groups. 

  1. Enterotype 1,  has high numbers of a bacterium called Bacterioides and this type has a greater capacity to make the vitamin B7 or biotin. 

  2. Enterotype 2 has dominant numbers of a different bacterium, Prevotella, and provides more vitamin B1 or Thiamine.  

  3. Enterotype 3 is dominated by the bacterium, Ruminococcus, related to weight control, sugar methabolism.

  • It is easy, take and send the sample of your stool with our kit
  • It is personalized, request the analysis of the bacterial strains of interest
  • It is intuitive, discover and interpret your results with our report.
natgene.com gut flora

Comparison between healthy gut flora and unhealthy person with pathogenic bacteria


First seven Bacteria discovered during a Natgene Flora test.

Some of them are pathogenic


ISO 9001:2008  

Quality management systems

ISO 17025:2005

General requirements for the competence of testing and calibration laboratories

Tecnology and automation

MIUR award for human, animal and plant genotyping

Laboratory Information Management System

In collaboration with LIFE Technologies Corporation

CE-IVD Protocols

In Vitro Diagnostic Medical Devices

Validation and Method

Quality Control (QC) for reproducibility assessment

European Society of Human Genetics (ESHG)

In accordance with the guidelines for genetic testing

Technological District of Life Sciences

Toscana Life Science (TLS) Tuscany Region

Privacy policies according with European law (UE) 2016/679 - Data Protection 
NATGENE®. is committed to protecting patient privacy. All of genetic testing and any personal information or results are kept under strict confidentiality.
All this being said that ... NATGENE® provides an analysis and scientific interpretation of selected genomic markers, called polymorphisms, that are associated with specific risks and health benefits. Being carriers of a genetic risk variant for a given disease, it does not mean necessarily that this disease will develop, as well as have some genetic risk variant does not eliminate the chance of developing the disease. Prevention strategies can be developed and completed. They can effectively reduce the chance of developing a disease or they can help manage the consequences of the same effectively. Therefore NATGENE® urges you to consult qualified doctors for diagnosis and for answers to personal questions about the test results. NATGENE® declines any responsibility for any deviations from the original text, and refers, in the case of any doubt, the related scientific literature. NATGENE®. is committed to protecting patient privacy. All of genetic testing and any personal information or results are kept under strict confidentiality. The data relating to the patient's DNA will not be used for other diagnostic tests outside of those ordered by the patient and will not be used for scientific purposes, unless otherwise indicated by the patient. The genomic information of a patient will be directly associated with the personal information gathered in the patient's anamnesis form. In no circumstances this information will be released to third parties, in order to reveal information, unless there is consent from the patient. The genomic information of a patient will not be disclosed outside of NATGENE® either within the company, except for those who draw up the medical report, the confidential report on the analysis and the final report, unless the patient has given his consent, unless required by law. The information contained in the confidential report is meant as an additional tool for the physician and should not be considered a genetic diagnosis of one or more diseases, or identify an existing medical condition, or confirm / replace a diagnosis or medical condition from a health care professional. Under no circumstances NATGENE®assumes responsibility for the accuracy of the findings, diagnosis, and treatment of the recommendations described in the medical report. NATGENE® does not provide medical advice in the confidential report on the analysis, but makes available to physicians and biologists with industry scientific expertise to better understand the risks and benefits associated with the genotype identified. NATGENE® assumes no responsibility regarding the findings, diagnosis or treatment proposed by the physician or biologist who draws up the reporting. This statement is subject to Italian law.